Search

Inhibition of Abl Kinases by Intramolecular and Intermolecular Interactions: A Lesson from Structure Studies and CML Therapy

Journal: Current Enzyme Inhibition
Volume: 2 Issue: 2 Year: 2006 Page: 135-146
Author(s): Baojie Li

Analysis of the Molecular Determinants of the Response of Chronic Myelogenous Leukaemia to Tyrosine Kinase Inhibitors

Journal: Current Pharmacogenomics
Volume: 5 Issue: 3 Year: 2007 Page: 201-213
Author(s): Helene Labussiere, Sandrine Hayette, Franck E. Nicolini

Inhibition of Protein Kinase c-Src as a Therapeutic Approach for Cancer and Bone Metastases

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8 Issue: 3 Year: 2008 Page: 342-349
Author(s): Nadia Rucci, Maria Susa, Anna Teti

Glutamate Receptors and C-ABL Inhibitors: A New TherapeuticApproach for Parkinson's Disease

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 24 Issue: 1 Year: 2024 Page: 22-44
Author(s): Priya P. Shejul,Gaurav M. Doshi

Investigating the Activity of Indole-2-on Derivative Src Kinase Inhibitors AgainstChronic Myeloid Leukemia Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 1 Year: 2023 Page: 113-122
Author(s): Melek Tunc-Ata Tunc-Ata

Receptor Tyrosine Kinases and Anticancer Therapy

Journal: Current Pharmaceutical Design
Volume: 11 Issue: 9 Year: 2005 Page: 1139-1149
Author(s): Michael Medinger, Joachim Drevs

Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders

Journal: Current Drug Targets
Volume: 8 Issue: 2 Year: 2007 Page: 205-216
Author(s): Andreas Reiter, Christoph Walz, Nicholas C. P. Cross

Stem Cell Guardians – Old and New Perspectives in LSC Biology

Journal: Current Drug Targets
Volume: 18 Issue: 4 Year: 2017 Page: 405-413
Author(s): Gillian A. Horne,Lorna Jackson,Vignir Helgason,Tessa L. Holyoake

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 10 Issue: 1 Year: 2010 Page: 1-7
Author(s): Moustapha Zoubir, Thomas Tursz, Cedric Menard, Laurence Zitvogel, Nathalie Chaput

Dasatinib: An Anti-Tumour Agent via Src Inhibition

Journal: Current Drug Targets
Volume: 12 Issue: 4 Year: 2011 Page: 563-578
Author(s): Antonio Gnoni, Ilaria Marech, Nicola Silvestris, Angelo Vacca, Vito Lorusso